M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis

Antiangiogenic therapy for the treatment of cancer and other neovascular diseases is desired to be selective for pathological angiogenesis and lymphangiogenesis. Macrophage colony-stimulating factor (M-CSF), a cytokine required for the differentiation of monocyte lineage cells, promotes the formatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Yoshiaki, Takubo, Keiyo, Shimizu, Takatsune, Ohno, Hiroaki, Kishi, Kazuo, Shibuya, Masabumi, Saya, Hideyuki, Suda, Toshio
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715025/
https://www.ncbi.nlm.nih.gov/pubmed/19398755
http://dx.doi.org/10.1084/jem.20081605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715025/
https://www.ncbi.nlm.nih.gov/pubmed/19398755
http://dx.doi.org/10.1084/jem.20081605

Ejemplares similares